Trial Profile
Phase I, Prospective, Open-label, Multi-centric, Dose Finding Trial of Combination of IGEV and Panobinostat Before Autologous Stem Cell Transplant in Patients With Hodgkin's Lymphoma
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Panobinostat (Primary) ; Gemcitabine; Ifosfamide; Prednisolone; Vinorelbine
- Indications Hodgkin's disease
- Focus Adverse reactions
- 03 Jul 2013 New trial record